GH625: A milestone in understanding the many roles of membranotropic peptides

Biochimica et Biophysica Acta - Biomembranes

Volumn , Issue Part A, 2015, Pages 16-25

  Galdiero, Stefania ^a   Falanga, Annarita ^a   Morelli, Giancarlo ^a   Galdiero, Massimiliano ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Delivery; Fusion; Hydrophobicity; Membranotropic peptide; Viral inhibition

Indexed keywords

ANTIVIRUS AGENT; DOXORUBICIN; LIPOSOME; NANOPARTICLE; POLYSTYRENE; PROTEIN GH625; UNCLASSIFIED DRUG; VIRUS FUSION PROTEIN; VIRUS PROTEIN; GH625 PEPTIDE, HERPES SIMPLEX VIRUS TYPE I; PEPTIDE; VIRUS ENVELOPE PROTEIN;

BILAYER MEMBRANE; BLOOD BRAIN BARRIER; CELL MEMBRANE TRANSPORT; DRUG DELIVERY SYSTEM; DRUG DESIGN; HERPES SIMPLEX VIRUS 1; HUMAN; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR MECHANICS; NONHUMAN; REVIEW; VIRUS ENTRY; VIRUS INHIBITION; AMINO ACID SEQUENCE; CELL MEMBRANE; CHEMICAL STRUCTURE; CHEMISTRY; HERPES SIMPLEX; HOST PATHOGEN INTERACTION; METABOLISM; MOLECULAR GENETICS; PHYSIOLOGY; PROTEIN CONFORMATION; VIROLOGY;

AMINO ACID SEQUENCE; CELL MEMBRANE; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; HOST-PATHOGEN INTERACTIONS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PEPTIDES; PROTEIN CONFORMATION; VIRAL ENVELOPE PROTEINS;

EID: 84988246951     PISSN: 00052736     EISSN: 18792642     Source Type: Journal    
DOI: 10.1016/j.bbamem.2014.10.006     Document Type: Review

References (126)

1. D.J. Craik, D.P. Fairlie, S. Liras, and D. Price The future of peptide-based drugs Chem. Biol. Drug Des. 81 2013 136 147
2. P. Vlieghe, V. Lisowski, J. Martinez, and M. Khrestchatisky Synthetic therapeutic peptides: science and market Drug Discov. Today 15 2010 40 56
3. A.K. Sato, M. Viswanathan, R.B. Kent, and C.R. Wood Therapeutic peptides: technological advances driving peptides into development Curr. Opin. Biotechnol. 17 2006 638 642
4. W.M. Yau, W.C. Wimley, K. Gawrisch, and S.H. White The preference of tryptophan for membrane interfaces Biochemistry 37 1998 14713 14718
5. F. Harris, J. Wallace, and D.A. Phoenix Use of hydrophobic moment plot methodology to aid the identification of oblique orientated α-helices Mol. Membr. Biol. 17 2000 201 207
6. P. Joanne, P. Nicolas, and C. El Amri Antimicrobial peptides and viral fusion peptides: how different they are? Protein Pept. Lett. 16 2009 743 750
7. J. Cruz, C. Ortiz, F. Guzman, R. Fernandez-Lafuente, and R. Torres Antimicrobial peptides: promising compounds against pathogenic microorganisms Curr. Med. Chem. 21 2014 2299 2321
8. A. Falanga, M. Cantisani, C. Pedone, and S. Galdiero Membrane fusion and fission: enveloped viruses Protein Pept. Lett. 16 2009 751 759
9. F. Wang, Y. Wang, X. Zhang, W. Zhang, S. Guo, and F. Jin Recent progress of cell-penetrating peptides as new carriers for intracellular cargo delivery J. Control. Release 174 2014 126 136
10. S.C. Harrison Mechanism of membrane fusion by viral envelope proteins Adv. Virus Res. 64 2005 231 261
11. S.C. Harrison Viral membrane fusion Nat. Struct. Mol. Biol. 15 2008 690 698
12. I.A. Wilson, J.J. Skehel, and D.C. Wiley Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution Nature 289 1981 366 373
13. D. Fass, S.C. Harrison, and P.S. Kim Retrovirus envelope domain at 1.7 angstrom resolution Nat. Struct. Biol. 3 1996 465 469
14. W. Weissenhorn, A. Carfi, K.H. Lee, J.J. Skehel, and D.C. Wiley Crystal structure of the Ebola virus membrane fusion subunit, GP2, from the envelope glycoprotein ectodomain Mol. Cell 2 1998 605 616
15. H.S. Yin, X. Wen, R.G. Paterson, R.A. Lamb, and T.S. Jardetzky Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation Nature 439 2006 38 44
16. Y. Xu, Y. Liu, Z. Lou, L. Qin, X. Li, Z. Bai, H. Pang, P. Tien, G.F. Gao, and Z. Rao Structural basis for coronavirus-mediated membrane fusion. Crystal structure of mouse hepatitis virus spike protein fusion core J. Biol. Chem. 279 2004 30514 30522
17. F.A. Rey, F.X. Heinz, C. Mandl, C. Kunz, and S.C. Harrison The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution Nature 375 1995 291 298
18. J. Lescar, A. Roussel, M.W. Wien, J. Navaza, S.D. Fuller, G. Wengler, and F.A. Rey The fusion glycoprotein shell of Semliki Forest virus: an icosahedral assembly primed for fusogenic activation at endosomal pH Cell 105 2001 137 148
19. M. Backovic, and T. Jardetzky Class III viral membrane fusion proteins T. Dittmar, K.S. Zänker, Cell Fusion in Health and Disease 2011 Springer Netherlands 91 101
20. S.H. White, and W.C. Wimley Hydrophobic interactions of peptides with membrane interfaces Biochim. Biophys. Acta Rev. Biomembr. 1376 1998 339 352
21. W.C. Wimley, and S.H. White Experimentally determined hydrophobicity scale for proteins at membrane interfaces Nat. Struct. Biol. 3 1996 842 848
22. W.C. Wimley, K. Hristova, A.S. Ladokhin, L. Silvestro, P.H. Axelsen, and S.H. White Folding of β-sheet membrane proteins: a hydrophobic hexapeptide model J. Mol. Biol. 277 1998 1091 1110
23. A.S. Ladokhin, and S.H. White Folding of amphipathic α-helices on membranes: energetics of helix formation by melittin J. Mol. Biol. 285 1999 1363 1369
24. J.P. Segrest, H. De Loof, J.G. Dohlman, C.G. Brouillette, and G.M. Anantharamaiah Amphipathic helix motif: classes and properties Proteins Struct. Funct. Bioinforma. 8 1990 103 117
25. X. Han, and L.K. Tamm pH-dependent self-association of influenza hemagglutinin fusion peptides in lipid bilayers J. Mol. Biol. 304 2000 953 965
26. A. Sáez-Cirión, and J.L. Nieva Conformational transitions of membrane-bound HIV-1 fusion peptide Biochim. Biophys. Acta Biomembr. 1564 2002 57 65
27. X. Han, J.H. Bushweller, D.S. Cafiso, and L.K. Tamm Membrane structure and fusion-triggering conformational change of the fusion domain from influenza hemagglutinin Nat. Struct. Biol. 8 2001 715 720
28. L.K. Tamm, X. Han, Y. Li, and A.L. Lai Structure and function of membrane fusion peptides Biopolym. Pept. Sci. Sect. 66 2002 249 260
29. A. Agopian, and S. Castano Structure and orientation study of Ebola fusion peptide inserted in lipid membrane models Biochim. Biophys. Acta Biomembr. 1838 2014 117 126
30. B. Apellaniz, N. Huarte, E. Largo, and J.L. Nieva The three lives of viral fusion peptides Chem. Phys. Lipids 181 2014 40 55
31. A.L. Lai, A.E. Moorthy, Y. Li, and L.K. Tamm Fusion activity of HIV gp41 fusion domain is related to its secondary structure and depth of membrane insertion in a cholesterol-dependent fashion J. Mol. Biol. 418 2012 3 15
32. P. Larsson, and P.M. Kasson Lipid tail protrusion in simulations predicts fusogenic activity of influenza fusion peptide mutants and conformational models PLoS Comput. Biol. 9 2013 e1002950
33. M.M. Kozlov, H.T. McMahon, and L.V. Chernomordik Protein-driven membrane stresses in fusion and fission Trends Biochem. Sci. 35 2010 699 706
34. S.G. Peisajovich, O. Samuel, and Y. Shai Paramyxovirus F1 protein has two fusion peptides: implications for the mechanism of membrane fusion J. Mol. Biol. 296 2000 1353 1365
35. O. Samuel, and Y. Shai Participation of two fusion peptides in measles virus-induced membrane fusion: emerging similarity with other paramyxoviruses Biochemistry 40 2001 1340 1349
36. A.J. Perez-Berna, J. Guillen, M.R. Moreno, A. Bernabeu, G. Pabst, P. Laggner, and J. Villalain Identification of the membrane-active regions of hepatitis C virus p7 protein: biophysical characterization of the loop region J. Biol. Chem. 283 2008 8089 8101
37. A.J. Perez-Berna, M.R. Moreno, J. Guillen, A. Bernabeu, and J. Villalain The membrane-active regions of the hepatitis C virus E1 and E2 envelope glycoproteins Biochemistry 45 2006 3755 3768
38. H. Nemesio, F. Palomares-Jerez, and J. Villalain The membrane-active regions of the dengue virus proteins C and E Biochim. Biophys. Acta 1808 2011 2390 2402
39. H. Nemesio, M.F. Palomares-Jerez, and J. Villalain Hydrophobic segment of dengue virus C protein. Interaction with model membranes Mol. Membr. Biol. 30 2013 273 287
40. S. Galdiero, A. Falanga, M. Vitiello, H. Browne, C. Pedone, and M. Galdiero Fusogenic domains in herpes simplex virus type 1 glycoprotein H J. Biol. Chem. 280 2005 28632 28643
41. S. Galdiero, A. Falanga, M. Vitiello, M. D'Isanto, C. Collins, V. Orrei, H. Browne, C. Pedone, and M. Galdiero Evidence for a role of the membrane-proximal region of herpes simplex virus type 1 glycoprotein H in membrane fusion and virus inhibition Chembiochem 8 2007 885 895
42. S. Galdiero, M. Vitiello, M. D'Isanto, A. Falanga, M. Cantisani, H. Browne, C. Pedone, and M. Galdiero The identification and characterization of fusogenic domains in herpes virus glycoprotein B molecules Chembiochem 9 2008 758 767
43. M. Lorizate, N. Huarte, A. Saez-Cirion, and J.L. Nieva Interfacial pre-transmembrane domains in viral proteins promoting membrane fusion and fission Biochim. Biophys. Acta 1778 2008 1624 1639
44. S.G. Peisajovich, and Y. Shai Viral fusion proteins: multiple regions contribute to membrane fusion Biochim. Biophys. Acta 1614 2003 122 129
45. G. D'Errico, A.M. D'Ursi, and D. Marsh Interaction of a peptide derived from glycoprotein gp36 of feline immunodeficiency virus and its lipoylated analogue with phospholipid membranes Biochemistry 47 2008 5317 5327
46. H. Badani, R.F. Garry, and W.C. Wimley Peptide entry inhibitors of enveloped viruses: The importance of interfacial hydrophobicity Biochim. Biophys. Acta Biomembr 1838 2014 2180 2197
47. D. Rapaport, M. Ovadia, and Y. Shai A synthetic peptide corresponding to a conserved heptad repeat domain is a potent inhibitor of Sendai virus-cell fusion: an emerging similarity with functional domains of other viruses EMBO J. 14 1995 5524 5531
48. S. Galdiero, A. Falanga, M. Vitiello, M. D'Isanto, M. Cantisani, A. Kampanaraki, E. Benedetti, H. Browne, and M. Galdiero Peptides containing membrane-interacting motifs inhibit herpes simplex virus type 1 infectivity Peptides 29 2008 1461 1471
49. S. Galdiero, A. Falanga, M. Vitiello, L. Raiola, R. Fattorusso, H. Browne, C. Pedone, C. Isernia, and M. Galdiero Analysis of a membrane interacting region of herpes simplex virus type 1 glycoprotein H J. Biol. Chem. 283 2008 29993 30009
50. S. Galdiero, A. Falanga, M. Vitiello, L. Raiola, L. Russo, C. Pedone, C. Isernia, and M. Galdiero The presence of a single N-terminal histidine residue enhances the fusogenic properties of a membranotropic peptide derived from herpes simplex virus type 1 glycoprotein H J. Biol. Chem. 285 2010 17123 17136
51. Y. Xu, N.A. Rahman, R.B. Othman, P. Hu, and M. Huang Computational identification of self-inhibitory peptides from envelope proteins Proteins 80 2012 2154 2168
52. D.K. Chang, S.F. Cheng, C.H. Lin, E.B. Kantchev, and C.W. Wu Self-association of glutamic acid-rich fusion peptide analogs of influenza hemagglutinin in the membrane-mimic environments: effects of positional difference of glutamic acids on side chain ionization constant and intra- and inter-peptide interactions deduced from NMR and gel electrophoresis measurements Biochim. Biophys. Acta 1712 2005 37 51
53. W.L. Lau, D.S. Ege, J.D. Lear, D.A. Hammer, and W.F. DeGrado Oligomerization of fusogenic peptides promotes membrane fusion by enhancing membrane destabilization Biophys. J. 86 2004 272 284
54. Y. Kliger, A. Aharoni, D. Rapaport, P. Jones, R. Blumenthal, and Y. Shai Fusion peptides derived from the HIV type 1 glycoprotein 41 associate within phospholipid membranes and inhibit cell-cell fusion. Structure-function study J. Biol. Chem. 272 1997 13496 13505
55. M. Pritsker, P. Jones, R. Blumenthal, and Y. Shai A synthetic all D-amino acid peptide corresponding to the N-terminal sequence of HIV-1 gp41 recognizes the wild-type fusion peptide in the membrane and inhibits HIV-1 envelope glycoprotein-mediated cell fusion Proc. Natl. Acad. Sci. U. S. A. 95 1998 7287 7292
56. Y. Li, X. Han, and L.K. Tamm Thermodynamics of fusion peptide-membrane interactions Biochemistry 42 2003 7245 7251
57. W.G. Forssmann, Y.H. The, M. Stoll, K. Adermann, U. Albrecht, H.C. Tillmann, K. Barlos, A. Busmann, A. Canales-Mayordomo, G. Gimenez-Gallego, J. Hirsch, J. Jimenez-Barbero, D. Meyer-Olson, J. Munch, J. Perez-Castells, L. Standker, F. Kirchhoff, and R.E. Schmidt Short-term monotherapy in HIV-infected patients with a virus entry inhibitor against the gp41 fusion peptide Sci. Transl. Med. 2 2010 63re63
58. J. Münch, L. Ständker, K. Adermann, A. Schulz, M. Schindler, R. Chinnadurai, S. Pöhlmann, C. Chaipan, T. Biet, T. Peters, B. Meyer, D. Wilhelm, H. Lu, W. Jing, S. Jiang, W.G. Forssmann, and F. Kirchhoff Discovery and optimization of a natural HIV-1 entry inhibitor targeting the gp41 fusion peptide Cell 129 2007 263 275
59. V.P. Torchilin Multifunctional nanocarriers Adv. Drug Deliv. Rev. 58 2006 1532 1555
60. L.M. Bareford, and P.W. Swaan Endocytic mechanisms for targeted drug delivery Adv. Drug Deliv. Rev. 59 2007 748 758
61. J. He, W.B. Kauffman, T. Fuselier, S.K. Naveen, T.G. Voss, K. Hristova, and W.C. Wimley Direct cytosolic delivery of polar cargo to cells by spontaneous membrane-translocating peptides J. Biol. Chem. 288 2013 29974 29986
62. D. Guarnieri, A. Falanga, O. Muscetti, R. Tarallo, S. Fusco, M. Galdiero, S. Galdiero, and P.A. Netti Shuttle-mediated nanoparticle delivery to the blood-brain barrier Small 9 2013 853 862
63. S. Galdiero, A. Falanga, M. Vitiello, P. Grieco, M. Caraglia, G. Morelli, and M. Galdiero Exploitation of viral properties for intracellular delivery J. Pept. Sci. 20 2014 468 478
64. P.F. Almeida Membrane-active peptides: binding, translocation, and flux in lipid vesicles Biochim. Biophys. Acta 1838 2014 2216 2227
65. F. Heitz, M.C. Morris, and G. Divita Twenty years of cell-penetrating peptides: from molecular mechanisms to therapeutics Br. J. Pharmacol. 157 2009 195 206
66. E. Vivès, P. Brodin, and B. Lebleu Truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane J. Biol. Chem. 272 1997 16010 16017
67. A.M. Angeles-Boza, A. Erazo-Oliveras, Y.-J. Lee, and J.-P. Pellois Generation of endosomolytic reagents by branching of cell-penetrating peptides Bioconjug. Chem. 21 2010 2164 2167
68. S. Galdiero, M. Vitiello, A. Falanga, M. Cantisani, N. Incoronato, and M. Galdiero Intracellular delivery: exploiting viral membranotropic peptides Curr. Drug Metab. 13 2012 93 104
69. M.C. Morris, L. Chaloin, J. Mery, F. Heitz, and G. Divita A novel potent strategy for gene delivery using a single peptide vector as a carrier Nucleic Acids Res. 27 1999 3510 3517
70. M.C. Morris, P. Vidal, L. Chaloin, F. Heitz, and G. Divita A new peptide vector for efficient delivery of oligonucleotides into mammalian cells Nucleic Acids Res. 25 1997 2730 2736
71. W.R. Gallaher Detection of a fusion peptide sequence in the transmembrane protein of human immunodeficiency virus Cell 50 1987 327 328
72. D. Kalderon, and A.E. Smith In vitro mutagenesis of a putative DNA binding domain of SV40 large-T Virology 139 1984 109 137
73. M.G. Delboy, J.L. Patterson, A.M. Hollander, and A.V. Nicola Nectin-2-mediated entry of a syncytial strain of herpes simplex virus via pH-independent fusion with the plasma membrane of Chinese hamster ovary cells Virol. J. 3 2006 105
74. D.G. Roller, S.J. Dollery, J.L. Doyle, and A.V. Nicola Structure-function analysis of herpes simplex virus glycoprotein B with fusion-from-without activity Virology 382 2008 207 216
75. J. Arii, M. Uema, T. Morimoto, H. Sagara, H. Akashi, E. Ono, H. Arase, and Y. Kawaguchi Entry of herpes simplex virus 1 and other alphaherpesviruses via the paired immunoglobulin-like type 2 receptor alpha J. Virol. 83 2009 4520 4527
76. R.S. Milne, A.V. Nicola, J.C. Whitbeck, R.J. Eisenberg, and G.H. Cohen Glycoprotein D receptor-dependent, low-pH-independent endocytic entry of herpes simplex virus type 1 J. Virol. 79 2005 6655 6663
77. S.A. Connolly, J.O. Jackson, T.S. Jardetzky, and R. Longnecker Fusing structure and function: a structural view of the herpesvirus entry machinery Nat. Rev. Microbiol. 9 2011 369 381
78. A. Turner, B. Bruun, T. Minson, and H. Browne Glycoproteins gB, gD, and gHgL of herpes simplex virus type 1 are necessary and sufficient to mediate membrane fusion in a Cos cell transfection system J. Virol. 72 1998 873 875
79. A. Farnsworth, T.W. Wisner, M. Webb, R. Roller, G. Cohen, R. Eisenberg, and D.C. Johnson Herpes simplex virus glycoproteins gB and gH function in fusion between the virion envelope and the outer nuclear membrane Proc. Natl. Acad. Sci. U. S. A. 104 2007 10187 10192
80. A. Falanga, R. Tarallo, G. Vitiello, M. Vitiello, E. Perillo, M. Cantisani, G. D'Errico, M. Galdiero, and S. Galdiero Biophysical characterization and membrane interaction of the two fusion loops of glycoprotein B from herpes simplex type I virus PLoS One 7 2012 e32186
81. S. Galdiero, A. Falanga, G. Vitiello, M. Vitiello, C. Pedone, G. D'Errico, and M. Galdiero Role of membranotropic sequences from herpes simplex virus type I glycoproteins B and H in the fusion process Biochim. Biophys. Acta 1798 2010 579 591
82. S. Galdiero, L. Russo, A. Falanga, M. Cantisani, M. Vitiello, R. Fattorusso, G. Malgieri, M. Galdiero, and C. Isernia Structure and orientation of the gH625-644 membrane interacting region of herpes simplex virus type 1 in a membrane mimetic system Biochemistry 51 2012 3121 3128
83. T.K. Chowdary, T.M. Cairns, D. Atanasiu, G.H. Cohen, R.J. Eisenberg, and E.E. Heldwein Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL Nat. Struct. Mol. Biol. 17 2010 882 888
84. H. Matsuura, A.N. Kirschner, R. Longnecker, and T.S. Jardetzky Crystal structure of the Epstein-Barr virus (EBV) glycoprotein H/glycoprotein L (gH/gL) complex Proc. Natl. Acad. Sci. U. S. A. 107 2010 22641 22646
85. E.E. Heldwein, H. Lou, F.C. Bender, G.H. Cohen, R.J. Eisenberg, and S.C. Harrison Crystal structure of glycoprotein B from herpes simplex virus 1 Science 313 2006 217 220
86. S.A. Connolly, and R. Longnecker Residues within the C-terminal arm of the herpes simplex virus 1 glycoprotein B ectodomain contribute to its refolding during the fusion step of virus entry J. Virol. 86 2012 6386 6393
87. M. Cantisani, A. Falanga, N. Incoronato, L. Russo, A. De Simone, G. Morelli, R. Berisio, M. Galdiero, and S. Galdiero Conformational modifications of gB from herpes simplex virus type 1 analyzed by synthetic peptides J. Med. Chem. 56 2013 8366 8376
88. M. Backovic, R. Longnecker, and T.S. Jardetzky Structure of a trimeric variant of the Epstein-Barr virus glycoprotein B Proc. Natl. Acad. Sci. U. S. A. 106 2009 2880 2885
89. S. Roche, S. Bressanelli, F.A. Rey, and Y. Gaudin Crystal structure of the low-pH form of the vesicular stomatitis virus glycoprotein G Science 313 2006 187 191
90. J. Kadlec, S. Loureiro, N.G. Abrescia, D.I. Stuart, and I.M. Jones The postfusion structure of baculovirus gp64 supports a unified view of viral fusion machines Nat. Struct. Mol. Biol. 15 2008 1024 1030
91. S. Galdiero, M. Vitiello, M. D'Isanto, A. Falanga, C. Collins, K. Raieta, C. Pedone, H. Browne, and M. Galdiero Analysis of synthetic peptides from heptad-repeat domains of herpes simplex virus type 1 glycoproteins H and B J. Gen. Virol. 87 2006 1085 1097
92. R. Akkarawongsa, N.E. Pocaro, G. Case, A.W. Kolb, and C.R. Brandt Multiple peptides homologous to herpes simplex virus type 1 glycoprotein B inhibit viral infection Antimicrob. Agents Chemother. 53 2009 987 996
93. S. Galdiero, A. Falanga, R. Tarallo, L. Russo, E. Galdiero, M. Cantisani, G. Morelli, and M. Galdiero Peptide inhibitors against herpes simplex virus infections J. Pept. Sci. 19 2013 148 158
94. G. Vitiello, A. Falanga, M. Galdiero, D. Marsh, S. Galdiero, and G. D'Errico Lipid composition modulates the interaction of peptides deriving from herpes simplex virus type I glycoproteins B and H with biomembranes Biochim. Biophys. Acta 1808 2011 2517 2526
95. A. Krishnan, S.K. Verma, P. Mani, R. Gupta, S. Kundu, and D.P. Sarkar A histidine switch in hemagglutinin-neuraminidase triggers paramyxovirus-cell membrane fusion J. Virol. 83 2009 1727 1741
96. C. Chanel-Vos, and M. Kielian A conserved histidine in the ij loop of the Semliki Forest virus E1 protein plays an important role in membrane fusion J. Virol. 78 2004 13543 13552
97. R. Tarallo, T.P. Carberry, A. Falanga, M. Vitiello, S. Galdiero, M. Galdiero, and M. Weck Dendrimers functionalized with membrane-interacting peptides for viral inhibition Int. J. Nanomedicine 8 2013 521 534
98. A. Falanga, M.T. Vitiello, M. Cantisani, R. Tarallo, D. Guarnieri, E. Mignogna, P. Netti, C. Pedone, M. Galdiero, and S. Galdiero A peptide derived from herpes simplex virus type 1 glycoprotein H: membrane translocation and applications to the delivery of quantum dots Nanomedicine 7 2011 925 934
99. Y. Tu, and J.S. Kim A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes J. Gene Med. 10 2008 646 654
100. R. Tarallo, A. Accardo, A. Falanga, D. Guarnieri, G. Vitiello, P. Netti, G. D'Errico, G. Morelli, and S. Galdiero Clickable functionalization of liposomes with the gH625 peptide from Herpes simplex virus type I for intracellular drug delivery Chemistry 17 2011 12659 12668
101. T.P. Carberry, R. Tarallo, A. Falanga, E. Finamore, M. Galdiero, M. Weck, and S. Galdiero Dendrimer functionalization with a membrane-interacting domain of herpes simplex virus type 1: towards intracellular delivery Chemistry 18 2012 13678 13685
102. G. Smaldone, A. Falanga, D. Capasso, D. Guarnieri, S. Correale, M. Galdiero, P.A. Netti, M. Zollo, S. Galdiero, S. Di Gaetano, and E. Pedone gH625 is a viral derived peptide for effective delivery of intrinsically disordered proteins Int. J. Nanomedicine 8 2013 2555 2565
103. F. Pinaud, S. Clarke, A. Sittner, and M. Dahan Probing cellular events, one quantum dot at a time Nat. Methods 7 2010 275 285
104. I.L. Medintz, T. Pons, J.B. Delehanty, K. Susumu, F.M. Brunel, P.E. Dawson, and H. Mattoussi Intracellular delivery of quantum dot-protein cargos mediated by cell penetrating peptides Bioconjug. Chem. 19 2008 1785 1795
105. H. Lee, I.K. Kim, and T.G. Park Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis Bioconjug. Chem. 21 2010 289 295
106. J.B. Delehanty, C.E. Bradburne, K. Susumu, K. Boeneman, B.C. Mei, D. Farrell, J.B. Blanco-Canosa, P.E. Dawson, H. Mattoussi, and I.L. Medintz Spatiotemporal multicolor labeling of individual cells using peptide-functionalized quantum dots and mixed delivery techniques J. Am. Chem. Soc. 133 2011 10482 10489
107. E. Cukierman, and D.R. Khan The benefits and challenges associated with the use of drug delivery systems in cancer therapy Biochem. Pharmacol. 80 2010 762 770
108. G.R. Newkome, C.N. Moorefield, and F. Vögtle Dendrimers and Dendrons: Concepts, Synthesis, Applications 2001 Wiley-VCH Weinheim
109. C.C. Lee, J.A. MacKay, J.M.J. Fréchet, and F.C. Szoka Designing dendrimers for biological applications Nat. Biotechnol. 23 2005 1517 1526
110. E.R. Gillies, and J.M. Frechet Dendrimers and dendritic polymers in drug delivery Drug Discov. Today 10 2005 35 43
111. S. Gunaseelan, K. Gunaseelan, M. Deshmukh, X. Zhang, and P.J. Sinko Surface modifications of nanocarriers for effective intracellular delivery of anti-HIV drugs Adv. Drug Deliv. Rev. 62 2010 518 531
112. M. Najlah, and A. D'Emanuele Crossing cellular barriers using dendrimer nanotechnologies Curr. Opin. Pharmacol. 6 2006 522 527
113. F.P. Seib, A.T. Jones, and R. Duncan Comparison of the endocytic properties of linear and branched PEIs, and cationic PAMAM dendrimers in B16f10 melanoma cells J. Control. Release 117 2007 291 300
114. H. Kang, R. DeLong, M.H. Fisher, and R.L. Juliano Tat-conjugated PAMAM dendrimers as delivery agents for antisense and siRNA oligonucleotides Pharm. Res. 22 2005 2099 2106
115. C.T. Lu, Y.Z. Zhao, H.L. Wong, J. Cai, L. Peng, and X.Q. Tian Current approaches to enhance CNS delivery of drugs across the brain barriers Int. J. Nanomedicine 9 2014 2241 2257
116. N.J. Abbott, L. Ronnback, and E. Hansson Astrocyte-endothelial interactions at the blood-brain barrier Nat. Rev. Neurosci. 7 2006 41 53
117. S.D. Mahajan, W.C. Law, R. Aalinkeel, J. Reynolds, B.B. Nair, K.T. Yong, I. Roy, P.N. Prasad, and S.A. Schwartz Nanoparticle-mediated targeted delivery of antiretrovirals to the brain Methods Enzymol. 509 2012 41 60
118. K.K. Jain Nanobiotechnology-based strategies for crossing the blood-brain barrier Nanomedicine (Lond.) 7 2012 1225 1233
119. G. Orive, O.A. Ali, E. Anitua, J.L. Pedraz, and D.F. Emerich Biomaterial-based technologies for brain anti-cancer therapeutics and imaging Biochim. Biophys. Acta 1806 2010 96 107
120. R. Qiao, Q. Jia, S. Huwel, R. Xia, T. Liu, F. Gao, H.J. Galla, and M. Gao Receptor-mediated delivery of magnetic nanoparticles across the blood-brain barrier ACS Nano 6 2012 3304 3310
121. A. Falanga, R. Tarallo, E. Galdiero, M. Cantisani, M. Galdiero, and S. Galdiero Review of a viral peptide nanosystem for intracellular delivery J. Nanophotonics 7 2013 (071599-071599)
122. S. Valiante, A. Falanga, L. Cigliano, G. Iachetta, R.A. Busiello, V. La Marca, M. Galdiero, A. Lombardi, and S. Galdiero The peptide gH625 enters into neuron and astrocyte cell lines and crosses the blood brain barrier in rats 2014 (submitted for publication)
123. S. Fawell, J. Seery, Y. Daikh, C. Moore, L.L. Chen, B. Pepinsky, and J. Barsoum Tat-mediated delivery of heterologous proteins into cells Proc. Natl. Acad. Sci. 91 1994 664 668
124. M.P. Schutze-Redelmeier, H. Gournier, F. Garcia-Pons, M. Moussa, A.H. Joliot, M. Volovitch, A. Prochiantz, and F.A. Lemonnier Introduction of exogenous antigens into the MHC class I processing and presentation pathway by Drosophila antennapedia homeodomain primes cytotoxic T cells in vivo J. Immunol. 157 1996 650 655
125. C.V. Borlongan, and D.F. Emerich Facilitation of drug entry into the CNS via transient permeation of blood brain barrier: laboratory and preliminary clinical evidence from bradykinin receptor agonist, Cereport Brain Res. Bull. 60 2003 297 306
126. M.M. Patel, B.R. Goyal, S.V. Bhadada, J.S. Bhatt, and A.F. Amin Getting into the brain: approaches to enhance brain drug delivery CNS Drugs 23 2009 35 58